A miR-101 inhibitor significantly enhanced NEAT1-mediated stimulation of T24 and 5637 cells, whereas overexpression of VEGF-C abated the facilitating effects of the miR-101 inhibitor on BC cells. The gene discussed is NEAT1; the disease is breast cancer.